MedPath

Epitel, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System.

Not Applicable
Recruiting
Conditions
Seizures
Epilepsy
First Posted Date
2023-09-07
Last Posted Date
2024-08-27
Lead Sponsor
Epitel, Inc.
Target Recruit Count
65
Registration Number
NCT06027749
Locations
🇺🇸

University of South Florida, Tampa, Florida, United States

🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Assessment of Remote EEG Monitoring (REMI-EEG) in Pediatric Emergency and Adult Critical Care Units

Not Applicable
Conditions
Epilepsy
First Posted Date
2023-04-19
Last Posted Date
2024-01-25
Lead Sponsor
Epitel, Inc.
Target Recruit Count
129
Registration Number
NCT05818930
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

A Wireless EEG Patch for Continuous Electrographic Monitoring

Not Applicable
Conditions
Epilepsy
First Posted Date
2018-07-12
Last Posted Date
2024-02-16
Lead Sponsor
Epitel, Inc.
Target Recruit Count
750
Registration Number
NCT03583957
Locations
🇺🇸

University of Colorado Anschutz Medical Center, Aurora, Colorado, United States

🇺🇸

Boston Children's Hospital, Boston, Massachusetts, United States

🇺🇸

New York University Langone Medical Center, New York, New York, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.